Mobilizing serum factors and immune cells through exercise to counteract age-related changes in cancer risk.

ageing cancer development cancer growth-inhibitory molecular factors exercise immune-regulatory myokines immuno-surveillance

Journal

Exercise immunology review
ISSN: 1077-5552
Titre abrégé: Exerc Immunol Rev
Pays: Germany
ID NLM: 9505535

Informations de publication

Date de publication:
2020
Historique:
entrez: 7 3 2020
pubmed: 7 3 2020
medline: 26 3 2020
Statut: ppublish

Résumé

An increasing body of evidence suggests that age-related immune changes and chronic inflammation contribute to cancer development. Recognizing that exercise has protective effects against cancer, promotes immune function, and beneficially modulates inflammation with ageing, this review outlines the current evidence indicating an emerging role for exercise immunology in preventing and treating cancer in older adults. A specific focus is on data suggesting that muscle- derived cytokines (myokines) mediate anti-cancer effects through promoting immunosurveillance against tumourigenesis or inhibiting cancer cell viability. Previous studies suggested that the exercise-induced release of myokines and other endocrine factors into the blood increases the capacity of blood serum to inhibit cancer cell growth in vitro. However, little is known about whether this effect is influenced by ageing. Prostate cancer is the second most common cancer in men. We therefore examined the effects of serum collected before and after exercise from healthy young and older men on the metabolic activity of androgen-responsive LNCaP and androgen-unresponsive PC3 prostate cancer cells. Exercise-conditioned serum collected from the young group did not alter cell metabolic activity, whereas post-exercise serum (compared with pre-exercise serum) from the older men inhibited the metabolic activity of LNCaP cancer cells. Serum levels of candidate cancer-inhibitory myokines oncostatin M and osteonectin increased in both age groups following exercise. Serum testosterone increased only in the younger men postexercise, potentially attenuating inhibitory effects of myokines on the LNCaP cell viability. The data from our study and the evidence in this review suggest that mobilizing serum factors and immune cells may be a key mechanism of how exercise counteracts cancer in the older population.

Identifiants

pubmed: 32139350

Substances chimiques

Osteonectin 0
Oncostatin M 106956-32-5

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

80-99

Informations de copyright

Copyright © 2020 International Society of Exercise and Immunology. All rights reserved.

Auteurs

Ji Hui Hwang (JH)

School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.

Jacqui McGovern (J)

Centre in Regenerative Medicine, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.

Geoffrey M Minett (GM)

School of Exercise and Nutrition Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.

Paul A Della Gatta (PA)

Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Sciences Deakin University, Geelong, Australia.

Llion Roberts (L)

School of Allied Health Sciences, Griffith University, Gold Coast, Queensland, Australia.
School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, Australia.

Jonathan M Harris (JM)

School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.

Erik W Thompson (EW)

School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.
Translational Research Institute, Brisbane, Australia.

Tony J Parker (TJ)

School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.

Jonathan M Peake (JM)

School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.

Oliver Neubauer (O)

School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.
Center for Health Sciences and Medicine, Danube University Krems, Krems, Austria.
Research Platform Active Ageing, University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH